Esperion Therapeutics | ESPR - Crediti Commerciali

Prezzo Delle Azioni
2.59
Cambio Giornaliero
0.04 1.37%
Mensile
-21.67%
Annuale
48.56%
Q1 Previsione
2.47




Crediti Commerciali Cambiamento Data
AbbVie USD 12.77B 132M 2025-09
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Alterity Therapeutics Limited AUD 8.67M 1.59M 2023-06
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.57B 1.08B 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Cipla INR 74.61B 19.39B 2025-09
CSL USD 4.32B 1.35B 2025-12
Cytokinetics USD 1.81M 6.6M 2025-09
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Geron USD 37.66M 1.71M 2025-09
Grifols EUR 1B 285.88M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Nektar Therapeutics USD 0 2.9M 2024-09
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
United Therapeutics USD 350.2M 52.5M 2025-12
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12